Free Trial

Quest Diagnostics (DGX) Short Interest Ratio & Short Volume

$141.28
+1.24 (+0.89%)
(As of 05/24/2024 ET)

Quest Diagnostics Short Interest Data

Current Short Interest
2,800,000 shares
Previous Short Interest
3,020,000 shares
Change Vs. Previous Month
-7.28%
Dollar Volume Sold Short
$386.90 million
Short Interest Ratio
2.9 Days to Cover
Last Record Date
April 30, 2024
Outstanding Shares
111,090,000 shares
Float Size
110,600,000 shares
Short Percent of Float
2.53%
Today's Trading Volume
647,499 shares
Average Trading Volume
912,856 shares
Today's Volume Vs. Average
71%
cover of A Guide to High-Short-Interest Stocks and How to Trade Them ebook
Short Selling Quest Diagnostics ?

Sign up to receive the latest short interest report for Quest Diagnostics and its competitors with MarketBeat's FREE newsletter.

Skip Charts & View Short Interest History

DGX Short Interest Over Time

DGX Days to Cover Over Time

DGX Percentage of Float Shorted Over Time

Quest Diagnostics Short Interest History

Report DateTotal Shares Sold ShortDollar Volume Sold ShortChange from Previous ReportPercentage of Float ShortedDays to CoverPrice on Report Date
4/30/20242,800,000 shares $386.90 million -7.3%2.5%2.9 $138.18
4/15/20243,020,000 shares $388.49 million +18.4%2.8%2.8 $128.64
3/31/20242,550,000 shares $339.43 million -3.8%2.3%2.4 $133.11
3/15/20242,650,000 shares $339.94 million -3.6%2.4%2.6 $128.28
2/29/20242,750,000 shares $343.45 million -7.4%2.5%2.6 $124.89
2/15/20242,970,000 shares $373.42 million -13.7%2.7%2.9 $125.73
1/31/20243,440,000 shares $441.76 million +13.2%3.1%3.5 $128.42
1/15/20243,040,000 shares $411.31 million +22.1%2.7%3.1 $135.30
12/31/20232,490,000 shares $343.32 million -2.4%2.2%2.7 $137.88
12/15/20232,550,000 shares $344.33 million +12.3%2.3%2.7 $135.03
11/30/20232,270,000 shares $311.51 million -15.6%2.0%2.5 $137.23
11/15/20232,690,000 shares $364.41 million +7.2%2.4%3 $135.47
10/31/20232,510,000 shares $326.55 million -15.5%2.3%2.9 $130.10
10/15/20232,970,000 shares $363.83 million +2.1%2.7%3.6 $122.50
9/30/20232,910,000 shares $354.61 million +3.9%2.6%3.8 $121.86
9/15/20232,800,000 shares $353.42 million -4.8%2.5%3.6 $126.22
8/31/20232,940,000 shares $386.61 million -9.5%2.6%3.6 $131.50
8/15/20233,250,000 shares $434.01 million +0.6%2.9%3.7 $133.54
7/31/20233,230,000 shares $436.73 million +6.6%2.9%3.6 $135.21
7/15/20233,030,000 shares $425.53 million -10.1%2.7%3.2 $140.44
6/30/20233,370,000 shares $473.69 million -10.4%3.0%3.5 $140.56
6/15/20233,760,000 shares $515.65 million -7.2%3.4%3.8 $137.14
5/31/20234,050,000 shares $537.27 million -0.7%3.7%3.8 $132.66
5/15/20234,080,000 shares $540.19 million -4.0%3.7%3.7 $132.40
4/30/20234,250,000 shares $589.94 million +3.2%3.8%3.7 $138.81
4/15/20234,120,000 shares $586.44 million +15.1%3.7%3.6 $142.34
3/31/20233,580,000 shares $506.50 million +19.3%3.2%3 $141.48
3/15/20233,000,000 shares $398.55 million -9.6%2.7%2.5 $132.85
2/28/20233,320,000 shares $459.36 million +8.9%3.0%2.9 $138.36
2/15/20233,050,000 shares $447.19 million +11.3%2.8%2.9 $146.62
1/31/20232,740,000 shares $406.84 million -17.0%2.4%2.4 $148.48
1/15/20233,300,000 shares $488.20 million -12.5%2.9%2.9 $147.94
12/30/20223,770,000 shares $589.78 million -5.8%3.3%3.4 $156.44
12/15/20224,000,000 shares $596.88 million -12.3%3.5%3.6 $149.22
11/30/20224,560,000 shares $692.34 million -13.8%4.0%4.2 $151.83
11/15/20225,290,000 shares $782.60 million +5.6%4.7%5.1 $147.94
10/31/20225,010,000 shares $719.69 million +2.5%4.4%5.1 $143.65
10/15/20224,890,000 shares $616.68 million -6.3%4.3%5.3 $126.11
9/30/20225,220,000 shares $640.44 million -5.6%4.5%6.1 $122.69
9/15/20225,530,000 shares $687.27 million +2.4%4.8%6.6 $124.28
Elon to Transform U.S. Economy? (Ad)

A radical, potentially game-changing technology that threatens to destroy the trillion-dollar, “green energy” grift of the elites. And yet, while it threatens their wealth and power, it could be transformational for both the U.S. economy and your wealth.

One company holds a near-total monopoly on it.
8/31/20225,400,000 shares $676.67 million +10.4%4.7%6.4 $125.31
8/15/20224,890,000 shares $689.98 million +2.1%4.2%5.6 $141.10
7/31/20224,790,000 shares $654.17 million +3.0%4.1%5.3 $136.57
7/15/20224,650,000 shares $631.75 million +0.9%4.0%4.8 $135.86
6/30/20224,610,000 shares $613.04 million -5.5%4.0%4.7 $132.98
6/15/20224,880,000 shares $628.45 million -0.2%4.2%4.6 $128.78
5/31/20224,890,000 shares $689.59 million +3.2%4.2%4.4 $141.02
5/15/20224,740,000 shares $646.49 million -2.1%4.1%4.1 $136.39
4/30/20224,840,000 shares $647.79 million -8.5%4.2%4.1 $133.84
4/15/20225,290,000 shares $719.02 million -3.3%4.5%4.1 $135.92
3/31/20225,470,000 shares $748.62 million -6.2%4.6%4.2 $136.86
3/15/20225,830,000 shares $825.82 million +0.5%4.9%4.6 $141.65
2/28/20225,800,000 shares $761.37 million +16.5%4.9%4.7 $131.27
2/15/20224,980,000 shares $652.93 million +27.4%4.1%3.9 $131.11
1/31/20223,910,000 shares $527.93 million +20.3%3.2%3.1 $135.02
1/15/20223,250,000 shares $462.48 million +13.2%2.7%2.8 $142.30
12/31/20212,870,000 shares $496.54 million -18.2%2.4%2.3 $173.01
12/15/20213,510,000 shares $591.12 million -27.2%2.9%2.7 $168.41
11/30/20214,820,000 shares $716.64 million +4.6%4.0%3.7 $148.68
11/15/20214,610,000 shares $675.83 million +11.9%3.8%3.6 $146.60
10/29/20214,120,000 shares $604.73 million -4.2%3.4%3.2 $146.78
10/15/20214,300,000 shares $612.75 million -2.9%3.5%3.4 $142.50
9/30/20214,430,000 shares $643.72 million -11.0%3.7%3.8 $145.31
9/15/20214,980,000 shares $775.83 million -16.2%4.1%4.6 $155.79
8/31/20215,940,000 shares $907.81 million -6.6%4.9%5.8 $152.83
8/13/20216,360,000 shares $942.68 million -11.7%5.3%6.1 $148.22
7/30/20217,200,000 shares $1.02 billion -11.3%6.0%6.5 $141.80
7/15/20218,120,000 shares $1.09 billion -6.7%6.7%7.2 $134.07
6/30/20218,700,000 shares $1.15 billion -6.6%6.7%7.6 $131.97
6/15/20219,310,000 shares $1.19 billion -5.1%7.2%8 $128.17
5/28/20219,810,000 shares $1.29 billion -5.3%7.6%8.4 $131.67
5/14/202110,360,000 shares $1.42 billion -3.5%8.0%8.4 $137.47
4/30/202110,740,000 shares $1.41 billion +197.5%8.3%8.6 $131.46
4/15/20213,610,000 shares $459.70 million -6.2%2.8%2.8 $127.34
3/31/20213,850,000 shares $494.69 million +0.3%2.9%2.9 $128.49
3/15/20213,840,000 shares $467.98 million +14.3%2.9%2.8 $121.87
2/26/20213,360,000 shares $385.16 million +33.9%2.5%2.5 $114.63
2/12/20212,510,000 shares $313.90 million -6.0%1.9%1.9 $125.06
1/29/20212,670,000 shares $330.33 million -4.3%2.0%2.1 $123.72
1/15/20212,790,000 shares $348.67 million -1.1%2.1%2.3 $124.97
12/31/20202,820,000 shares $333.69 million +10.6%2.1%2.4 $118.33
12/15/20202,550,000 shares $314.06 million +8.1%1.9%2.3 $123.16
11/30/20202,360,000 shares $294.53 million -4.8%1.8%2.1 $124.80
11/15/20202,480,000 shares $301.37 million +23.4%1.9%1.9 $121.52
10/30/20202,010,000 shares $247.17 million -0.5%1.5%1.6 $122.97
10/15/20202,020,000 shares $237.59 million +1.0%1.5%1.6 $117.62
9/30/20202,000,000 shares $228.98 million -27.0%1.5%1.5 $114.49
9/15/20202,740,000 shares $311.24 million -4.5%2.1%1.9 $113.59
8/31/20202,870,000 shares $319.26 million No Change2.2%2 $111.24
8/14/20202,870,000 shares $344.43 million +4.0%2.2%2.1 $120.01
Elon to Transform U.S. Economy? (Ad)

A radical, potentially game-changing technology that threatens to destroy the trillion-dollar, “green energy” grift of the elites. And yet, while it threatens their wealth and power, it could be transformational for both the U.S. economy and your wealth.

One company holds a near-total monopoly on it.
7/31/20202,760,000 shares $350.71 million -13.5%2.1%1.9 $127.07
7/15/20203,190,000 shares $391.44 million -6.2%2.4%1.9 $122.71
6/30/20203,400,000 shares $375.43 million +3.3%2.6%2 $110.42
6/15/20203,290,000 shares $371.05 million -16.1%2.5%1.7 $112.78
5/29/20203,920,000 shares $462.83 million -15.7%3.0%1.8 $118.07
5/15/20204,650,000 shares $516.52 million -16.7%3.5%2.1 $111.08
4/30/20205,580,000 shares $614.41 million -3.0%4.2%2.6 $110.11
4/15/20205,750,000 shares $512.04 million -3.9%4.3%3 $89.05
3/31/20205,980,000 shares $637.59 million +7.2%4.5%3.6 $106.62
3/13/20205,578,200 shares $500.76 million +57.1%4.2%5.3 $89.77
2/28/20203,550,000 shares $266.75 million -4.3%2.7%3.3 $75.14
2/14/20203,710,000 shares $394.52 million -1.3%2.8%4.5 $106.34
1/31/20203,760,000 shares $413.34 million -2.6%2.8%4.8 $109.93
1/15/20203,860,000 shares $433.67 million -2.8%2.9%4.9 $112.35
12/31/20193,970,000 shares $427.93 million +14.4%3.0%4.9 $107.79
8/15/20193,988,700 shares $404.10 million -11.9%3.0%4.3 $101.31

DGX Short Interest - Frequently Asked Questions

What is Quest Diagnostics' current short interest?

Short interest is the volume of Quest Diagnostics shares that have been sold short but have not yet been covered or closed out. As of April 30th, traders have sold 2,800,000 shares of DGX short. 2.53% of Quest Diagnostics' shares are currently sold short. Learn More on Quest Diagnostics' current short interest.

What is a good short interest ratio for Quest Diagnostics?

The short interest ratio, also known as the "days to cover ratio", is calculated by dividing the number of shares of a stock sold short divided by its average trading volume. A short interest ratio ranging between 1 and 4 generally indicates strong positive sentiment about a stock and a lack of short sellers. A short interest ratio of 10 or greater indicates strong pessimism about a stock. DGX shares currently have a short interest ratio of 3.0. Learn More on Quest Diagnostics's short interest ratio.

Which institutional investors are shorting Quest Diagnostics?

As of the most recent reporting period, the following institutional investors, funds, and major shareholders have reported short positions of Quest Diagnostics: Walleye Trading LLC, Jane Street Group LLC, PEAK6 Investments LLC, and Concourse Financial Group Securities Inc.. These positions are disclosed in Form 13F filings with the Securities and Exchange Commission.

What is a good short interest percentage for Quest Diagnostics?

Companies that have a short interest as a percentage of float below 10% indicates positive investor sentiment and few short sellers. Stocks with a short interest percentage above 10% is considered high, suggesting some investors are pessimistic about the stock. Companies with a short interest percentage of 20% or more indicates widespread negative sentiment. 2.53% of Quest Diagnostics' floating shares are currently sold short.

Is Quest Diagnostics' short interest increasing or decreasing?

Quest Diagnostics saw a decrease in short interest in the month of April. As of April 30th, there was short interest totaling 2,800,000 shares, a decrease of 7.3% from the previous total of 3,020,000 shares. Changes in short volume can be used to identify positive and negative investor sentiment. Investors that short sell a stock are betting that its price will decline in the future. An increase in short sale volume suggests bearish (negative) sentiment among investors. A decrease on short sale volume suggests bullish (positive) sentiment.

What is Quest Diagnostics' float size?

Quest Diagnostics currently has issued a total of 111,090,000 shares. Some of Quest Diagnostics' outstanding shares are available for trading, while others are subject to various restrictions. The public float, also referred to as floating shares or "the float", are shares that publicly owned, unrestricted and available to trade on the open market. Quest Diagnostics currently has a public float of 110,600,000 shares.

How does Quest Diagnostics' short interest compare to its competitors?

2.53% of Quest Diagnostics' shares are currently sold short. Here is how the short interest of companies in the sector of "medical" compare to Quest Diagnostics: Laboratory Co. of America Holdings (2.47%), Natera, Inc. (5.02%), Exact Sciences Co. (4.81%), RadNet, Inc. (4.36%), BeiGene, Ltd. (1.93%), Avantor, Inc. (3.68%), Illumina, Inc. (2.99%), BioMarin Pharmaceutical Inc. (2.06%), Hologic, Inc. (1.99%), Baxter International Inc. (1.97%),

Which stocks are the most shorted right now?

As of the most recent reporting period, the following stocks had the largest short interest positions: T-Mobile US, Inc. ($3.98 billion), Occidental Petroleum Co. ($3.35 billion), Charter Communications, Inc. ($3.06 billion), General Motors ($2.88 billion), Moderna, Inc. ($2.32 billion), Tractor Supply ($2.27 billion), Royal Caribbean Cruises Ltd. ($2.22 billion), Coinbase Global, Inc. ($2.18 billion), Williams-Sonoma, Inc. ($1.95 billion), and Chesapeake Energy Co. ($1.52 billion). View all of the most shorted stocks.

What does it mean to sell short Quest Diagnostics stock?

Short selling DGX is an investing strategy that aims to generate trading profit from Quest Diagnostics as its price is falling. DGX shares are trading up $1.24 today. To short a stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that a stock will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit.

How does a short squeeze work against Quest Diagnostics?

A short squeeze for Quest Diagnostics occurs when it has a large amount of short interest and its stock appreciates in price. This forces short sellers to cover their short interest positions by buying actual shares of DGX, which in turn drives the price of the stock up even further.

How often is Quest Diagnostics' short interest reported?

Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including DGX, twice per month. The most recent reporting period available is April, 30 2024.



More Short Interest Resources from MarketBeat

This page (NYSE:DGX) was last updated on 5/26/2024 by MarketBeat.com Staff

From Our Partners